Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T27457 | Target Info | |||
Target Name | Gamma-actin (ACTG) | ||||
Synonyms | Actin, cytoplasmic 2; ACTG | ||||
Target Type | Literature-reported Target | ||||
Gene Name | ACTG1 | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Ademetionine | Ligand Info | |||||
Structure Description | SETD3 mutant (N255V) in Complex with an Actin Peptide with His73 Replaced with Methionine | PDB:6WK2 | ||||
Method | X-ray diffraction | Resolution | 1.76 Å | Mutation | Yes | [1] |
PDB Sequence |
TLKYPIEMGI
75 VTNWDDMEK
|
|||||
|
||||||
Ligand Name: adenosine diphosphate | Ligand Info | |||||
Structure Description | Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution | PDB:5JLH | ||||
Method | Electron microscopy | Resolution | 3.90 Å | Mutation | No | [2] |
PDB Sequence |
EEEIAALVID
10 NGSGMCKAGF20 AGDDAPRAVF30 PSIVGRPRHQ40 GVMVGMGQKD50 SYVGDEAQSK 60 RGILTLKYPI70 EHGIVTNWDD80 MEKIWHHTFY90 NELRVAPEEH100 PVLLTEAPLN 110 PKANREKMTQ120 IMFETFNTPA130 MYVAIQAVLS140 LYASGRTTGI150 VMDSGDGVTH 160 TVPIYEGYAL170 PHAILRLDLA180 GRDLTDYLMK190 ILTERGYSFT200 TTAEREIVRD 210 IKEKLCYVAL220 DFEQEMATAA230 SSSSLEKSYE240 LPDGQVITIG250 NERFRCPEAL 260 FQPSFLGMES270 CGIHETTFNS280 IMKCDVDIRK290 DLYANTVLSG300 GTTMYPGIAD 310 RMQKEITALA320 PSTMKIKIIA330 PPERKYSVWI340 GGSILASLST350 FQQMWISKQE 360 YDESGPSIVH370 RKCF
|
|||||
|
ASP10
3.469
ASN11
4.797
GLY12
2.817
SER13
2.427
GLY14
4.433
MET15
3.496
LYS17
3.227
GLN136
4.335
GLY155
3.078
ASP156
2.560
GLY157
4.497
GLY181
3.417
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Characterization of SETD3 methyltransferase-mediated protein methionine methylation. J Biol Chem. 2020 Aug 7;295(32):10901-10910. | ||||
REF 2 | Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution. Nature. 2016 Jun 30;534(7609):724-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.